Cme (CME) Cost of Revenue (2009 - 2026)

Cme (CME) has 18 years of Cost of Revenue data on file, last reported at $52.5 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $52.5 million, down 3.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $246.7 million (down 7.01% YoY), and the FY2025 annual result was $248.5 million, down 7.14% from the prior year.
• Cost of Revenue retreated to $52.5 million in Q1 2026 per CME's latest filing, from $85.9 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $101.9 million in Q4 2023 and troughed at $43.9 million in Q3 2022.
• A 5-year average of $63.9 million and a median of $56.6 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue gained 28.7% in 2023, then retreated 11.56% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $95.0 million in 2022, then grew by 7.26% to $101.9 million in 2023, then declined by 11.29% to $90.4 million in 2024, then declined by 4.98% to $85.9 million in 2025, then plunged by 38.88% to $52.5 million in 2026.
• Business Quant data shows CME's Cost of Revenue at $52.5 million in Q1 2026, $85.9 million in Q4 2025, and $55.1 million in Q3 2025.